I really hope the quarterly more informative than that rubbish from Arrowhead. It's riddled with errors. They quote the 52 week range at "$1.50-$4.50", rehash some info from past announcements and don't even bother to update the body of the report from last time. I was interested to read about Fiale only to find things like "The company expects to release its resource review in Q1 2012" Waste of time and money.
It's really unfortunate as the report could have been a great opportunity to get the message out.
EHR Price at posting:
1.5¢ Sentiment: Buy Disclosure: Held
